These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28586767)

  • 1. Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal.
    Clark WR; Leblanc M; Ricci Z; Ronco C
    Blood Purif; 2017; 44(2):140-155. PubMed ID: 28586767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose.
    Bellomo R; Mårtensson J; Lo S; Kaukonen KM; Cass A; Gallagher M; ;
    Blood Purif; 2016; 41(1-3):11-7. PubMed ID: 26485539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal replacement therapy in acute kidney injury from a Chinese cross-sectional study: patient, clinical, socioeconomic and health service predictors of treatment.
    Wang F; Hong D; Wang Y; Feng Y; Wang L; Yang L;
    BMC Nephrol; 2017 May; 18(1):152. PubMed ID: 28472927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose in continuous renal replacement therapy.
    Claure-Del Granado R
    Gac Med Mex; 2018; 154(Supp 1):S40-S47. PubMed ID: 30074025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.
    Vásquez Jiménez E; Anumudu SJ; Neyra JA
    Nephron; 2021; 145(2):91-98. PubMed ID: 33540417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription and Delivery of the Right Continuous Renal Replacement Therapies Dose.
    Villa G; Neri M; Ronco C; Cerdá J
    Contrib Nephrol; 2018; 194():38-50. PubMed ID: 29597217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Continuous Renal Replacement Therapy and Solute Control.
    Bagshaw SM; Chakravarthi MR; Ricci Z; Tolwani A; Neri M; De Rosa S; Kellum JA; Ronco C;
    Blood Purif; 2016; 42(3):238-47. PubMed ID: 27562079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What dialysis dose should be provided in acute renal failure? A review.
    Leblanc M; Tapolyai M; Paganini EP
    Adv Ren Replace Ther; 1995 Jul; 2(3):255-64. PubMed ID: 7614362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operational characteristics of continuous renal replacement modalities used for critically ill patients with acute kidney injury.
    Huang Z; Letteri JJ; Clark WR; Ronco C; Gao D
    Int J Artif Organs; 2008 Jun; 31(6):525-34. PubMed ID: 18609505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal replacement therapy for AKI: When? How much? When to stop?
    Romagnoli S; Clark WR; Ricci Z; Ronco C
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):371-385. PubMed ID: 29248144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with end-stage renal disease (ESRD) under chronic hemodialysis requiring continuous renal replacement therapy (CRRT) and patients without ESRD in acute kidney injury requiring CRRT: a single-center study.
    Jung YS; Lee J; Shin HS; Rim H
    Hemodial Int; 2012 Oct; 16(4):456-64. PubMed ID: 22541135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose determinants in continuous renal replacement therapy.
    Clark WR; Turk JE; Kraus MA; Gao D
    Artif Organs; 2003 Sep; 27(9):815-20. PubMed ID: 12940904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea reduction ratio may be a simpler approach for measurement of adequacy of intermittent hemodialysis in acute kidney injury.
    Liang KV; Zhang JH; Palevsky PM
    BMC Nephrol; 2019 Mar; 20(1):82. PubMed ID: 30841863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomenclature for renal replacement therapy in acute kidney injury: basic principles.
    Neri M; Villa G; Garzotto F; Bagshaw S; Bellomo R; Cerda J; Ferrari F; Guggia S; Joannidis M; Kellum J; Kim JC; Mehta RL; Ricci Z; Trevisani A; Marafon S; Clark WR; Vincent JL; Ronco C;
    Crit Care; 2016 Oct; 20(1):318. PubMed ID: 27719682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis.
    Claure-Del Granado R; Macedo E; Chertow GM; Soroko S; Himmelfarb J; Ikizler TA; Paganini EP; Mehta RL
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):467-75. PubMed ID: 21115626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Veno-Venous High Cut-Off Hemodialysis Compared to Continuous Veno-Venous Hemodiafiltration in Intensive Care Unit Acute Kidney Injury Patients.
    Balgobin S; Morena M; Brunot V; Besnard N; Daubin D; Platon L; Larcher R; Amigues L; Landreau L; Bargnoux AS; Dupuy AM; Cristol JP; Klouche K
    Blood Purif; 2018; 46(3):248-256. PubMed ID: 29972818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Survey on the Management of Acute Kidney Injury and Continuous Renal Replacement Therapies: Year 2018.
    Digvijay K; Neri M; Fan W; Ricci Z; Ronco C
    Blood Purif; 2019; 47(1-3):113-119. PubMed ID: 30269144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients.
    Schiffl H
    Int Urol Nephrol; 2010 Jun; 42(2):435-40. PubMed ID: 20383609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal replacement therapy in acute renal failure: solute removal mechanisms and dose quantification.
    Clark WR; Ronco C
    Kidney Int Suppl; 1998 May; 66():S133-7. PubMed ID: 9573590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.